{
    "root": "d7253a99-928d-4f20-aa67-786837f19411",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Carisoprodol",
    "value": "20250203",
    "ingredients": [
        {
            "name": "CARISOPRODOL",
            "code": "21925K482H"
        },
        {
            "name": "HYPROMELLOSE 2910 (50 MPA.S)",
            "code": "1IVH67816N"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE 101",
            "code": "7T9FYH5QMK"
        },
        {
            "name": "SODIUM STARCH GLYCOLATE TYPE A POTATO",
            "code": "5856J3G2A2"
        },
        {
            "name": "STEARIC ACID",
            "code": "4ELV7Z65AP"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U"
        }
    ],
    "indications": "Carisoprodol is indicated for the relief of discomfort associated with acute, painful musculoskeletal conditions in adults.\n                  \n                     Limitation of Use\n                     Carisoprodol should only be used for short periods (up to two or three weeks) because adequate evidence of effectiveness for more prolonged use has not been established and because acute, painful musculoskeletal conditions are generally of short duration. [see \n                     \n                        Dosage and Administration (2)\n                     ].",
    "contraindications": "The recommended dose of carisoprodol is 350 mg three times a day and at bedtime.The recommended maximum duration of carisoprodol use is up to two or three weeks.",
    "warningsAndPrecautions": "350 mg Tablets: round, convex, white tablets, inscribed with 111 on one side and “O” on the other side.\n                  \n                     NDC 71335-9621-1: 14 Tablets in a BOTTLE\n                     NDC 71335-9621-2: 28 Tablets in a BOTTLE\n                     NDC 71335-9621-3: 60 Tablets in a BOTTLE\n                     NDC 71335-9621-4: 20 Tablets in a BOTTLE\n                     NDC 71335-9621-5: 30 Tablets in a BOTTLE\n                     NDC 71335-9621-6: 84 Tablets in a BOTTLE\n                     NDC 71335-9621-7: 90 Tablets in a BOTTLE\n                     NDC 71335-9621-8: 100 Tablets in a BOTTLE\n                     NDC 71335-9621-9: 120 Tablets in a BOTTLE\n                     NDC 71335-9621-0: 56 Tablets in a BOTTLE\n                  \n                  StorageStore at controlled room temperature 20° - 25°C (68° - 77°F).\n                  Repackaged/Relabeled by:Bryant Ranch Prepack, Inc.Burbank, CA 91504",
    "adverseReactions": "Carisoprodol is contraindicated in patients with a history of acute intermittent porphyria or a hypersensitivity reaction to a carbamate such as meprobamate."
}